Drug development
Cara Therapeutics develops medicines for conditions like itching and pain, then advances those candidates through lab work and clinical testing. It also works with outside partners on some programs.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Cara Therapeutics is a biopharmaceutical company that develops prescription medicines for severe itch and pain. Its work has centered on drug candidates that act on the body’s opioid receptors, especially the kappa opioid receptor, which it studies as a way to relieve symptoms without relying on traditional painkillers. In simple terms, it is a drug developer, not a drug distributor or clinic operator.
The company makes money the way many biotech firms do: by advancing drug programs through research, clinical testing, and regulatory review, then seeking value through licensing deals, partnerships, or eventual product sales if a medicine is approved. Its main customers are not patients directly at first, but drugmakers, healthcare systems, and eventually doctors and pharmacies if a product reaches the market. For investors, the key business question is whether its drug candidates can prove safe and effective enough to become approved treatments.
What makes Cara different is its focus on a narrow biology target rather than a broad portfolio of medicines. That gives it a clear role in the drug development chain: it tries to turn specialized science into therapies for conditions where current treatment options are limited or come with unwanted side effects.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more